{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T01:54:36Z","timestamp":1793325276184,"version":"4.5.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"\n Background<\/jats:title>\n Diabetes ketoacidosis (DKA) is a common and serious acute complication of diabetes mellitus. Globally, its incidence is on the rise, posing a serious threat to the life, health and quality of life of diabetic patients. In current clinical practice, although a variety of indicators are used to determine DKA, these indicators often have a lag and cannot effectively predict the occurrence of DKA at an early stage, resulting in some patients missing the best time for treatment.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To investigate the risk factors for the development of DKA and establish a prediction model based on the information of type II diabetes mellitus.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n A total of 288 patients were collected in this study out of which 74 patients developed DKA. The patients enrolled in this study were randomly divided into a training set and a validation set according to a ratio of 7:3, with 201 patients in the training set and 87 patients in the validation set. The patients\u2019 past medical history, dietary habits and relevant information during hospitalization were collected separately to study the correlation factors affecting the emergence of DKA in patients and to establish a prediction model.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Possibly relevant factors were included in a one-way logistic regression, and after analyzing the results: history of infection, dietary status, duration of diabetes mellitus longer than 3 years, history of smoking, history of alcohol consumption, abnormalities in liver function, abnormalities in HbA1c, and hypokalaemia were potential risk factors for the development of DKA,\n P<\/jats:italic>\n &lt; 0.2; The data obtained were further included in a multifactorial review: history of infection, dietary status (intemperate diet), duration of diabetes mellitus more than 3 years, HbA1c abnormality, and hypokalaemia were predictive factors for DKA (\n P<\/jats:italic>\n &lt; 0.05).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n This model provides a predictive tool for clinicians to identify high-risk patients with DKA at an early stage, which can help to take targeted preventive and intervention measures before the onset of the disease. However, the model was developed and internally validated using hospital-based data and that external validation is required before wider clinical application.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fmed.2025.1638927","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:09:02Z","timestamp":1761894542000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Construction and validation of a clinical prediction model for diabetic ketoacidosis"],"prefix":"10.3389","volume":"12","author":[{"given":"Chen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications.","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention.","volume":"20","author":"Wong","year":"2023","journal-title":"Nat Rev Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-021-05585-2","article-title":"Interpreting global trends in type 2 diabetes complications and mortality.","volume":"65","author":"Ali","year":"2022","journal-title":"Diabetologia."},{"key":"B4","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1177\/2047487319878371","article-title":"Diabetes as a cardiovascular risk factor: an overview of global trends of macro and micro vascular complications.","volume":"26","author":"Dal Canto","year":"2019","journal-title":"Eur J Prev Cardiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.4093\/dmj.2023.0244","article-title":"Risk prediction and management of chronic kidney disease in people living with type 2 diabetes mellitus.","volume":"48","author":"Ooi","year":"2024","journal-title":"Diabetes Metab J."},{"key":"B6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12882-020-1709-z","article-title":"The incidence, risk factors, and long-term outcomes of acute kidney injury in hospitalized diabetic ketoacidosis patients.","volume":"21","author":"Chen","year":"2020","journal-title":"BMC Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12902-021-00792-9","article-title":"Correlation between PCT, 25(OH)D, PTX-3, AMS levels and the severity of diabetic ketoacidosis complicated by pancreatitis.","volume":"21","author":"Lu","year":"2021","journal-title":"BMC Endocr Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1462330","DOI":"10.3389\/fendo.2024.1462330","article-title":"Association between SOFA score and risk of acute kidney injury in patients with diabetic ketoacidosis: an analysis of the MIMIC-IV database.","volume":"15","author":"Hua","year":"2024","journal-title":"Front Endocrinol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.mcna.2016.12.011","article-title":"Management of hyperglycemic crises: diabetic ketoacidosis and hyperglycemic hyperosmolar state.","volume":"101","author":"Fayfman","year":"2017","journal-title":"Med Clin North Am."},{"key":"B10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nrendo.2016.15","article-title":"Diabetic emergencies \u2013 ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia.","volume":"12","author":"Umpierrez","year":"2016","journal-title":"Nat Rev Endocrinol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11892-017-0857-4","article-title":"Treatment of diabetic ketoacidosis (DKA)\/hyperglycemic hyperosmolar state (HHS): novel advances in the management of hyperglycemic crises (UK Versus USA).","volume":"17","author":"Dhatariya","year":"2017","journal-title":"Curr Diab Rep."},{"key":"B12","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/pedi.13406","article-title":"ISPAD clinical practice consensus guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state.","volume":"23","author":"Glaser","year":"2022","journal-title":"Pediatr Diabetes."},{"key":"B13","first-page":"727","article-title":"Predicting type 1 diabetes onset using novel survival analysis with biomarker ontology.","volume":"2020","author":"Li","year":"2020","journal-title":"AMIA Annu Symp Proc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/pedi.12701","article-title":"ISPAD clinical practice consensus guidelines 2018: diabetic ketoacidosis and the hyperglycemic hyperosmolar state.","volume":"19","author":"Wolfsdorf","year":"2018","journal-title":"Pediatr Diabetes."},{"key":"B15","first-page":"729","article-title":"Hyperosmolar hyperglycemic state.","volume":"96","author":"Stoner","year":"2017","journal-title":"Am Fam Phys."},{"key":"B16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3760\/cma.j.cn112138-20211027-00751","article-title":"[Clinical guidelines for prevention and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)].","volume":"61","year":"2022","journal-title":"Zhonghua Nei Ke Za Zhi."},{"key":"B17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.21037\/atm-20-1604","article-title":"Prognostic significance of chemokines CCL11 and CCL5 modulated by low-density lipoprotein cholesterol in colon cancer patients with normal body mass index.","volume":"9","author":"Wang","year":"2021","journal-title":"Ann Transl Med."},{"key":"B18","first-page":"2432","article-title":"A meta-analysis of the correlation between non-steroidal anti-inflammatory drugs and recurrent colorectal adenomatous polyps.","volume":"13","author":"Zhang","year":"2021","journal-title":"Am J Transl Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1344277","DOI":"10.3389\/fendo.2024.1344277","article-title":"Feature selection and risk prediction for diabetic patients with ketoacidosis based on MIMIC-IV.","volume":"15","author":"Liu","year":"2024","journal-title":"Front Endocrinol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12916-023-02906-7","article-title":"A multicentre, prospective, non-interventional study evaluating the safety of dapagliflozin in patients with type 2 diabetes in routine clinical practice in China (DONATE).","volume":"21","author":"Guo","year":"2023","journal-title":"BMC Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1080\/17446651.2024.2353723","article-title":"Unmasking the escalation: a comparative analysis of diabetic ketoacidosis severity before and during the COVID-19 pandemic in a Tunisian pioneer study.","volume":"19","author":"Gorchane","year":"2024","journal-title":"Expert Rev Endocrinol Metab."},{"key":"B22","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/s2213-8587(21)00019-x","article-title":"Anti-interleukin-21 antibody and liraglutide for the preservation of \u03b2-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.","volume":"9","author":"von Herrath","year":"2021","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/s2213-8587(15)00436-2","article-title":"Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial.","volume":"4","author":"Dejgaard","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"932086","DOI":"10.3389\/fmed.2022.932086","article-title":"From disease and patient heterogeneity to precision medicine in type 1 diabetes.","volume":"9","author":"den Hollander","year":"2022","journal-title":"Front Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"613s","DOI":"10.3945\/an.115.010314","article-title":"The effects of breakfast consumption and composition on metabolic wellness with a focus on carbohydrate metabolism.","volume":"7","author":"Maki","year":"2016","journal-title":"Adv Nutr."},{"key":"B26","doi-asserted-by":"publisher","first-page":"923120","DOI":"10.3389\/fnut.2022.923120","article-title":"Effect of high-fat and low-fat dairy products on cardiometabolic risk factors and immune function in a low birthweight swine model of diet-induced insulin resistance.","volume":"9","author":"She","year":"2022","journal-title":"Front Nutr."},{"key":"B27","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/s41574-020-0381-5","article-title":"Diet and exercise in the prevention and treatment of type 2 diabetes mellitus.","volume":"16","author":"Magkos","year":"2020","journal-title":"Nat Rev Endocrinol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.2337\/dc20-1690","article-title":"important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in france: the RELIEF study.","volume":"44","author":"Roussel","year":"2021","journal-title":"Diabetes Care."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e3408","DOI":"10.1002\/dmrr.3408","article-title":"Features and long-term outcomes of patients hospitalized for diabetic ketoacidosis.","volume":"37","author":"Michaelis","year":"2021","journal-title":"Diabetes Metab Res Rev."},{"key":"B30","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12933-024-02256-5","article-title":"Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study.","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/ndt\/gfab243","article-title":"HbA1c and beyond.","volume":"38","author":"Rossing","year":"2023","journal-title":"Nephrol Dial Transplant."},{"key":"B32","doi-asserted-by":"publisher","first-page":"111889","DOI":"10.1016\/j.diabres.2024.111889","article-title":"Prediabetes and diabetes in India: an HbA1c based epidemiology study.","volume":"217","author":"Vora","year":"2024","journal-title":"Diabetes Res Clin Pract."},{"key":"B33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/5584_2020_545","article-title":"Acute metabolic emergencies in diabetes: DKA, HHS and EDKA.","volume":"1307","author":"Muneer","year":"2021","journal-title":"Adv Exp Med Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e14788","DOI":"10.1111\/dme.14788","article-title":"The management of diabetic ketoacidosis in adults-an updated guideline from the Joint british diabetes society for inpatient care.","volume":"39","author":"Dhatariya","year":"2022","journal-title":"Diabet Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"e15005","DOI":"10.1111\/dme.15005","article-title":"Management of hyperosmolar hyperglycaemic state (HHS) in adults: an updated guideline from the joint british diabetes societies (JBDS) for inpatient care group.","volume":"40","author":"Mustafa","year":"2023","journal-title":"Diabet Med."},{"key":"B36","doi-asserted-by":"publisher","first-page":"105049","DOI":"10.1016\/j.ijmedinf.2023.105049","article-title":"Machine learning prediction models and nomogram to predict the risk of in-hospital death for severe DKA: a clinical study based on MIMIC-IV, eICU databases, and a college hospital ICU.","volume":"174","author":"Xie","year":"2023","journal-title":"Int J Med Inform."},{"key":"B37","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1089\/dia.2024.0484","article-title":"Predicting and ranking diabetic ketoacidosis risk among youth with type 1 diabetes with a clinic-to-clinic transferrable machine learning model.","volume":"27","author":"Vandervelden","year":"2025","journal-title":"Diabetes Technol Ther."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1087297","DOI":"10.3389\/fpubh.2023.1087297","article-title":"Predicting the risk factors of diabetic ketoacidosis-associated acute kidney injury: a machine learning approach using XGBoost.","volume":"11","author":"Fan","year":"2023","journal-title":"Front Public Health."},{"key":"B39","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1038\/s41598-025-85357-9","article-title":"Machine learning based prediction models for the prognosis of COVID-19 patients with DKA.","volume":"15","author":"Xiang","year":"2025","journal-title":"Sci Rep."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1638927\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:09:04Z","timestamp":1761894544000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1638927\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":39,"alternative-id":["10.3389\/fmed.2025.1638927"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1638927","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"1638927"}}